| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.68B | 20.49B | 18.91B | 19.39B | 20.46B | 19.75B |
| Gross Profit | 6.43B | 6.25B | 5.64B | 5.46B | 5.51B | 5.11B |
| EBITDA | 2.45B | 2.37B | 2.37B | 1.84B | 1.52B | 1.23B |
| Net Income | 2.24B | 2.11B | 1.54B | 1.27B | 978.42M | 789.85M |
Balance Sheet | ||||||
| Total Assets | 20.99B | 21.53B | 19.40B | 18.73B | 17.84B | 16.99B |
| Cash, Cash Equivalents and Short-Term Investments | 11.35B | 11.15B | 9.90B | 9.20B | 9.36B | 8.35B |
| Total Debt | 23.07M | 29.97M | 60.08M | 102.12M | 153.93M | 214.81M |
| Total Liabilities | 6.95B | 7.30B | 7.15B | 8.09B | 7.71B | 7.65B |
| Stockholders Equity | 14.04B | 14.23B | 12.25B | 10.63B | 10.13B | 9.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.20B | 1.18B | 697.70M | 1.25B | 106.02M |
| Operating Cash Flow | 0.00 | 2.21B | 1.51B | 1.17B | 1.57B | 250.10M |
| Investing Cash Flow | 0.00 | -415.29M | -316.29M | -636.51M | -63.03M | -103.80M |
| Financing Cash Flow | 0.00 | -507.69M | -504.39M | -693.15M | -403.19M | -1.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥31.95B | 8.18 | ― | 2.93% | 2.11% | 5.55% | |
76 Outperform | ¥26.08B | 13.36 | ― | 3.93% | 11.90% | 69.40% | |
74 Outperform | ¥28.35B | 16.05 | ― | 2.45% | 19.04% | 30.67% | |
69 Neutral | ¥31.46B | 13.32 | ― | 2.22% | 9.57% | 315.38% | |
68 Neutral | ¥26.94B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
65 Neutral | ¥30.85B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |